Valuation: Össur hf.

Market Cap 1.73B 217B 1.51B 1.39B 1.29B 2.42B 166B 2.48B 16.66B 6.55B 81.54B 6.49B 6.35B 281B P/E 2026 *
18.7x
P/E 2027 * 15.9x
Enterprise Value 2.13B 267B 1.86B 1.72B 1.58B 2.98B 205B 3.05B 20.51B 8.07B 100B 7.99B 7.82B 345B EV / Sales 2026 *
2.09x
EV / Sales 2027 * 1.9x
Free-Float
36.17%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 48 01/04/2022
Director of Finance/CFO 60 01/09/2022
Chief Tech/Sci/R&D Officer - 24/02/2025
Director TitleAgeSince
Chairman 68 01/01/2006
Director/Board Member 61 01/02/2008
Director/Board Member 58 01/01/2009
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+0.33% - - 1.73B
-0.99%-5.74%-5.43%-29.77% 19.75B
-0.87%+1.18%-10.70%-12.48% 15.23B
-3.07%-3.40%-60.20%-48.13% 5.64B
-0.86%+14.77% - - 4.25B
-2.49%+4.13%+42.90%+8.69% 1.66B
-5.54%-0.29%-39.63%-61.35% 1.25B
-2.00%+5.45%+75.42%+131.86% 894M
+0.70%-0.65%+14.18%+166.49% 444M
-8.35%-9.17% - - 240M
Average -2.33%+0.88%+2.36%+22.19% 5.48B
Weighted average by Cap. -1.24%+0.88%-11.46%-20.51%

Financials

2026 *2027 *
Net sales 1.02B 128B 890M 821M 757M 1.43B 98.05B 1.46B 9.81B 3.86B 48.02B 3.82B 3.74B 165B 1.1B 138B 961M 887M 818M 1.54B 106B 1.58B 10.6B 4.17B 51.87B 4.13B 4.04B 179B
Net income 93.16M 11.68B 81.41M 75.13M 69.25M 131M 8.97B 133M 898M 353M 4.39B 350M 342M 15.13B 108M 13.55B 94.49M 87.19M 80.37M 151M 10.41B 155M 1.04B 410M 5.1B 406M 397M 17.55B
Net Debt 399M 49.98B 348M 322M 296M 559M 38.4B 571M 3.84B 1.51B 18.81B 1.5B 1.46B 64.74B 358M 44.82B 312M 288M 266M 501M 34.43B 512M 3.45B 1.36B 16.86B 1.34B 1.31B 58.05B
Logo Össur hf.
Embla Medical hf, formerly Ossur hf, is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The Company's business activities are divided into three business segment: The Prosthetics, its product portfolio includes a range of lower and upper limb prosthetic components; The Bracing & Supports, which offers the Unloader One range of knee braces that relieve pain from knee osteoarthritis, as well as the Unloader Hip which is designed to reduce pain by optimizing load dispersion for patients suffering from mild and moderate osteoarthritis of the hip; and The Patient Care, which operates a network of Patient Care clinics around the world, with each one catering to individual patients and their needs.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
26.50DKK
Average target price
32.90DKK
Spread / Average Target
+24.15%

Quarterly revenue - Rate of surprise